President of Americas, Cordis
Appears in 1 story
Leading US commercialization of SELUTION SLR
The FDA on September 21 approved the first drug-eluting balloon for coronary use in the United States. Cordis' SELUTION SLR expands inside a narrowed artery, releases the drug sirolimus into the vessel wall for up to 90 days, and is removed — no permanent implant stays behind.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
